Drug Profile
DM 83
Alternative Names: DM-83Latest Information Update: 03 Jan 2017
Price :
$50
*
At a glance
- Originator DiaMedica
- Class Antihyperglycaemics
- Mechanism of Action Neurotransmitter stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 29 Dec 2016 DiaMedica is now called DiaMedica Therapeutics
- 31 Oct 2010 Discontinued - Phase-II for Type-2 diabetes mellitus in European Union (PO)